Your browser doesn't support javascript.
Melanoma care during one year pandemic in Berlin: decreasing appointment cancellations despite increasing COVID-19 concern.
Micek, Aleksandra; Diehl, Katharina; Teuscher, Miriam; Schaarschmidt, Marthe-Lisa; Sasama, Bianca; Ohletz, Jan; Burbach, Guido; Kiecker, Felix; Hillen, Uwe; Harth, Wolfgang; Peitsch, Wiebke K.
  • Micek A; Department of Dermatology and Allergology, Vivantes Klinikum Spandau, Berlin, Germany.
  • Diehl K; Faculty of Medicine, Charité, University Medicine Berlin, Berlin, Germany.
  • Teuscher M; Mannheim Institute of Public Health, Social and Preventive Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Schaarschmidt ML; Department of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Sasama B; Department of Dermatology and Phlebology, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
  • Ohletz J; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
  • Burbach G; Department of Dermatology and Phlebology, Vivantes Klinikum im Friedrichshain, Berlin, Germany.
  • Kiecker F; Department of Dermatology and Allergology, Vivantes Klinikum Spandau, Berlin, Germany.
  • Hillen U; Department of Dermatology and Allergology, Vivantes Klinikum Spandau, Berlin, Germany.
  • Harth W; Department of Dermatology and Venereology, Vivantes Klinikum Neukölln, Berlin, Germany.
  • Peitsch WK; Department of Dermatology and Venereology, Vivantes Klinikum Neukölln, Berlin, Germany.
J Dtsch Dermatol Ges ; 20(7): 962-978, 2022 07.
Article in English | MEDLINE | ID: covidwho-1879014
ABSTRACT
BACKGROUND AND

OBJECTIVES:

The COVID-19 pandemic poses a great challenge for cancer patients. Our aim was to assess its influence on treatment and appointments of melanoma patients after one year of pandemic.

METHODS:

Melanoma patients treated in the Vivantes Skin Cancer Centre in Berlin, Germany completed a postal survey on pandemic-related alterations in melanoma care. Impact factors on changes of appointments were examined with descriptive analyses and multivariate logistic regression. Data after one year of pandemic were compared to those after its first wave.

RESULTS:

Among 366 participants (57.7 % males; mean age 69.2 years, response rate 36.1 %), 38 (10.1 %) reported postponed or missed appointments, mostly on their own demand (71.1 %) due to fear of COVID-19 (52.6 %). Current treatment was associated with a lower risk of changing appointments (Odds Ratio [OR] 0.194, p = 0.002), higher age (OR 1.037, p = 0.039), longer disease duration (OR 1.007, p = 0.028), and higher school degree (OR 2.263, p = 0.043) with higher probability. Among 177 patients currently receiving therapy, only 1.7 % experienced pandemic-related treatment alterations. Concern about COVID-19 was significantly higher after one year of pandemic than after its first wave, but the number of missed appointments was lower.

CONCLUSIONS:

Pandemic-related changes were rare in our cohort and decreased over time despite increasing concern.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Melanoma Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male Country/Region as subject: Europa Language: English Journal: J Dtsch Dermatol Ges Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Ddg.14799

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Melanoma Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male Country/Region as subject: Europa Language: English Journal: J Dtsch Dermatol Ges Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Ddg.14799